Comparison of antibody-based immunotherapeutics for malignant hematological disease in an experimental murine model

•New mouse model allows for side-by-side comparison of antitumor activity and side effects of immunotherapeutics targeting the same epitope.•Immunotherapies can be studied in a syngeneic or an allogeneic setting following stem cell transplant.